Clinical trial
EEG Biomarkers for Predicting Response to Antidepressant Therapy
NCT00289523 · Medtronic - MITG, Industry · Completed
Key facts
| NCT number | NCT00289523 |
|---|---|
| Title | EEG Biomarkers for Predicting Response to Antidepressant Therapy |
| Official title | Biomarkers for Rapid Identification of Treatment Effectiveness in Major Depression (BRITE-MD), a Prospective, Randomized, Multi-center Study to Determine the Efficacy of Selected EEG and Genotype Biomarkers for Predicting Response to Antidepressant Therapy With Escitalopram, Bupropion XL, or a… |
| Lead sponsor | Medtronic - MITG, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Major Depressive Disorder |
| Enrollment | 375 |
| Start date | Jan 1, 2006 |
| Primary completion | Jul 1, 2007 |
| Completion | Jul 1, 2007 |
| First posted | Feb 10, 2006 |
| Last update posted | Mar 7, 2012 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: